CURES Reports at Rehab Admission: What Prescribers See

, ,
Clinician meeting with an adult in residential treatment for treatment-resistant depression with alcohol use disorder

If you or someone you love is coming into residential treatment while taking a prescribed controlled medication, such as a benzodiazepine for anxiety, a stimulant for ADHD, a sleep medication, or an opioid for pain, the admitting prescriber will almost certainly look up a CURES report before writing a single order. Families are often surprised by this, and some people feel accused by it. It is neither a trap nor a judgement. It is a routine safety step, and knowing what the report shows, and what it does not, makes the admission conversation shorter, calmer and more accurate.

What a CURES Report Is, in One Paragraph

CURES, the Controlled Substance Utilization Review and Evaluation System, is California’s prescription drug monitoring program, run by the California Department of Justice. When a California pharmacy dispenses a Schedule II, III, IV or V controlled medication, the fill is reported to CURES, which means a licensed prescriber can see a person’s recent dispensed controlled prescriptions, including the drug, strength, quantity, days’ supply, fill date, prescriber and pharmacy. At a six-bed residential program like Annandale in Pasadena, a CURES check is one of the first things done at admission for anyone taking a controlled medication, because it is the fastest independent way to confirm what has actually been dispensed before detox medications are ordered.

Why the Prescriber Checks It Before Ordering Anything

Detox and early residential care involve prescribing medications that interact with the very drugs a person may already be taking. A clinician planning an alcohol withdrawal protocol, for example, needs to know whether a benzodiazepine is already on board, at what dose and for how long. California law also generally requires prescribers to consult CURES before starting many Schedule II through IV medications, so the check is a legal expectation as well as good practice.

The reasons it matters clinically fall into a few clear groups:

  • Dose accuracy: A taper plan has to start from the real daily dose, and fill quantities and days’ supply help confirm it.
  • Hidden overlap: Two prescribers writing similar medications, often without knowing about each other, shows up on the report as parallel fills.
  • Withdrawal risk: Stopping alcohol or a benzodiazepine suddenly can cause seizures, so knowing exact exposure shapes how closely someone must be medically supervised.
  • Overdose risk: Combining opioids with benzodiazepines, alcohol or other sedatives raises the risk of dangerous breathing suppression, a pattern NIDA describes in its overview of prescription medicine misuse.
  • Co-occurring care: For someone in dual diagnosis treatment, the report helps the psychiatric prescriber see which medications for anxiety, sleep, ADHD or pain have been part of the picture alongside the substance use.

What CURES Does Not Show

This is the part we explain to families most often, because a “clean” or short CURES report can be misread as a complete history. In our admissions work, the report is a starting point, not the whole story. It generally does not capture:

  • Alcohol and illicit drugs: Nothing bought outside a pharmacy appears, including counterfeit pills that look like real prescriptions.
  • Pills from someone else: Medication shared by a friend or family member shows under that person’s name, not the patient’s.
  • Out-of-state fills: Prescriptions filled in another state may or may not appear, depending on data-sharing between programs.
  • Online or overseas purchases: Medications ordered from non-US websites or bought abroad are invisible to the system.
  • Clinic-dosed methadone: Methadone given daily at an opioid treatment program is often not reflected in pharmacy-based reporting, so it has to be confirmed directly with the clinic.
  • Non-controlled medications: Most antidepressants and many mood stabilisers are not controlled substances and will not appear, so a full medication list is still needed.

It also shows what was dispensed, not what was taken. A 30-day fill used up in ten days and a 30-day fill still half full in a drawer look identical on paper. That is why the admission conversation always pairs the report with the person’s own account.

What to Do Before the Admission Call Today

You do not need to obtain the report yourself; the prescriber will run it. What you can do, today, is make the comparison easy. Take ten minutes and write out a simple table with five columns:

  • The medication name and strength on the bottle.
  • The prescriber’s name and the pharmacy that filled it.
  • The date of the most recent fill.
  • How much is actually being taken per day right now, honestly, even if it differs from the label.
  • The time of the last dose.

Bring every bottle, including empty ones, in a single bag. Then, at the admission appointment, ask one direct question: “Have you pulled my CURES report, and can we go through it line by line together?” Most of the confusion we see at intake comes from an old prescription someone forgot, or a second prescriber nobody mentioned. Reviewing it together, out loud, catches that in minutes. Our guide on building a medication list for rehab admission covers the non-controlled medications that belong on the same sheet.

When the Report and Your Account Do Not Match

Mismatches are common and are not, on their own, a reason to refuse admission. A clinician’s job is to work out a safe plan, not to catch anyone out. Typical explanations include a prescription transferred between pharmacies, an early refill before travel, a prescriber who left a practice, or a dose that crept up without the prescription changing.

The most useful thing you can do is say plainly what is going on. If someone has been taking more than prescribed, or supplementing with pills from another source, that information directly changes the withdrawal plan. For benzodiazepines in particular, underestimating the real daily amount is one of the ways a taper ends up too fast, which can raise seizure risk. Our benzodiazepine detox team would far rather hear an uncomfortable number than plan around a comfortable one.

Privacy is a fair concern. Substance use treatment records have additional federal confidentiality protections, and CURES access is restricted to authorised users for defined purposes. If you are worried about who will learn about treatment, ask the admissions team how your information is handled before you arrive; you can call us at (855) 778-8668 and ask that question first.

How This Fits Into Residential and Dual Diagnosis Care

For many people we admit, a controlled prescription started for a real reason: a benzodiazepine prescribed during a period of panic, an opioid after surgery, a stimulant for ADHD that became harder to manage alongside drinking. When a substance use disorder and a mental health condition are present together, both need a plan. In dual diagnosis treatment, the CURES review helps the psychiatric and addiction medicine sides agree on which medications to continue, which to taper under supervision, and which to replace with non-controlled alternatives.

The American Society of Addiction Medicine clinical guidelines emphasise individualised assessment of withdrawal risk and medication history rather than a one-size plan, and the CURES check is one practical tool for that assessment. It does not replace a physical exam, a urine drug screen or an honest interview; it sits alongside them.

A Note on Safety

Please do not stop a prescribed benzodiazepine, opioid or sleep medication on your own before admission to “clean up” a report. Abruptly stopping alcohol or benzodiazepines can cause seizures and other serious complications, and withdrawal from either should be medically supervised. Abruptly stopping opioids also lowers tolerance quickly, which raises overdose risk if use resumes. Keep taking medications as you have been, record exactly what you are taking, and let the medical team plan the change.

If you are unsure where to start, SAMHSA’s National Helpline at 1-800-662-4357 offers free, confidential treatment referral 24 hours a day. If someone is unresponsive, breathing slowly or cannot be woken, call 911. If you or someone you love is in emotional crisis, call or text 988.

Talk With Our Admissions Team

Annandale Behavioral Health is a small, licensed residential program in Pasadena providing medical detox and dual diagnosis care for adults with substance use disorders. If you have questions about medications, the CURES check, or whether residential care is the right level for you, call (855) 778-8668 to speak with our admissions team.

This article is for educational purposes only and is not medical or legal advice. Medication decisions, including whether to continue, taper or stop any prescription, should be made with a licensed prescriber who knows your full history. If this is an emergency, call 911.